The US Commodity Futures Trading Commission (CFTC) has overhauled its oversight of specific derivative market segments. According to an official letter, the agency has adopted a "no-action" position regarding several reporting mandates, specifically targeting swap data and participant recordkeeping.
Enforcement immunity
The CFTC’s Divisions of Market Oversight and Clearing & Risk announced they will not recommend enforcement actions against designated contract markets (DCMs) or derivatives clearing organizations (DCOs). This relief applies to failures in swap accounting and data repository reporting, provided the transactions involve fully collateralized event contracts.
A "no-action" position effectively grants temporary immunity. The regulator pledges not to pursue companies for specific technical infractions as long as the terms of the letter are upheld. This shift follows a wave of requests from DCMs and DCOs that list and clear these event-based instruments, which allow users to hedge risks or speculate on various real-world outcomes.
Slashing bureaucracy
The new policy is designed to slash bureaucracy for these platforms, the statement read.
Rather than issuing unique letters for every firm, the CFTC has established a unified registry as an appendix to the main document.
Any organization looking to operate with similar contracts can now simply request to join the existing no-action position. This streamlined approach allows officials to avoid redundant paperwork while ensuring equal treatment for both established players and newcomers.
The agency believes this framework will facilitate faster adaptation to shifting clearing house structures and evolving market demands. However, the no-action stance remains subject to change or revocation should regulatory conditions or DCM oversight requirements shift.
Read Also:
- SEC and CFTC Announce Reset of Cryptocurrency Regulation in the U.S.
- US Congress Calls For Ban On Insider Trading By Officials In Prediction Markets
- Prediction APIs That Beat Human Analysts (The Data Proof)
This post is for informational purposes only and does not constitute advertising or investment advice. Please do your own research before making any decisions.